Myovant Sciences Ltd (NYSE:MYOV)
| 26.83 Delayed Data As of Nov 28 |  +0.03 / +0.11%Today’s Change | 7.67 Today|||52-Week Range 26.90 | +72.32% Year-to-Date |
Latest MYOV News | Press Releases
No recent news for Myovant Sciences Ltd.
Today’s Trading
| Previous close | 26.80 |
| Today’s open | 26.80 |
| Day’s range | 26.79 - 26.84 |
| Volume | 520,165 |
| Average volume (3 months) | 1,473,584 |
| Market cap | $2.6B |
Data as of 4:00pm ET, 11/28/2022
Growth & Valuation
| Earnings growth (last year) | +21.82% |
| Earnings growth (this year) | +30.84% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +289.39% |
| P/E ratio | NM |
| Price/Sales | 5.36 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BPMCBlueprint Medicines ... | +0.34 | +0.76% |
| AXSMAxsome Therapeutics ... | +17.92 | +31.54% |
| ---- | ||
| ---- |
Data as of 4:00pm ET, 11/28/2022
Financials
| Next reporting date | February 14, 2023 |
| EPS forecast (this quarter) | -$0.45 |
| Annual revenue (last year) | $231.0M |
| Annual profit (last year) | -$206.0M |
| Net profit margin | -89.18% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters London, Greater London |
Forecasts
